4.7 Article

Pancreatic alpha cells in diabetic rats express active GLP-1 receptor: Endosomal co-localization of GLP-1/GLP-1R complex functioning through intra-islet paracrine mechanism

期刊

SCIENTIFIC REPORTS
卷 8, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41598-018-21751-w

关键词

-

资金

  1. Japan Society for the Promotion of Science [26461350]
  2. Novo Nordisk Pharma
  3. Sanwa Kagaku Kenkyusho
  4. Takeda
  5. Taisho Pharmaceutical Co., Ltd
  6. MSD
  7. Kowa
  8. Sumitomo Dainippon Pharma
  9. Novartis
  10. Mitsubishi Tanabe Pharma
  11. AstraZeneca
  12. Nippon Boehringer Ingelheim Co., Ltd
  13. Chugai
  14. Daiichi Sankyo
  15. Sanofi
  16. Novo Nordisk
  17. Lilly
  18. Boehringer Ingelheim
  19. Ono Pharma
  20. Kissei Pharma
  21. Astellas
  22. Taisho Pharma
  23. Grants-in-Aid for Scientific Research [16K09770, 26461350] Funding Source: KAKEN

向作者/读者索取更多资源

Glucagon-like peptide-1 (GLP-1) stimulates insulin secretion from pancreatic beta cells and suppresses glucagon secretion from alpha cells. It remains controversial, however, whether GLP-1 receptor (GLP-1R) is expressed in mature alpha cells. In this study, unlike previous studies using non-diabetic animals, we demonstrated using diabetic model rats and confocal laser scanning microscopy that the GLP-1/GLP-1R complex was located in the endosome of diabetic islets. In addition, we showed that GLP-1 and GLP-1R co-localized with various endosomal markers and adenylate cyclase in the alpha cells of diabetic rats. Diabetic rats had endosomal signaling pathway but normal rats had classical signaling pathway for activated GLP-1R. Furthermore, we performed pancreatic perfusion to assess the functional activity of GLP-1R when stimulated by exendin-4 (EX4). In a pancreas perfusion study, EX4 significantly stimulated glucagon secretion in diabetic rats but not normal rats. However, such glucagon secretion was immediately suppressed, probably due to concomitantly secreted insulin. The GLP-1/GLP-1R complex appears to function through an intra-islet paracrine mechanism in diabetic conditions which could explain, at least in part, the mechanism of paradoxical hyperglucagonaemia in type 2 diabetes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据